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Background: B7-homologue 3 (B7-H3), a recently identified immunoregulatory protein, has been shown to be
overexpressed in human hepatocellular carcinoma (HCC). However, whether the dynamic expression pattern of
B7-H3 contributes to early invasion of HCC is largely unknown. In addition, the biological roles of B7-H3 in HCC are
still unclear. Herein, we are going to examine B7-H3 expression profile and its clinicopathological significance in
primary and metastatic HCC, and further determine whether B7-H3 knockdown simulates different pathological
states of HCC progression and metastasis.
Methods: Using immunohistochemistry, B7-H3 expression was studied on 116 HCC containing primary and
metastatic HCCs. Survival curves and log-rank tests were used to test the association of B7-H3 expression with
survival. HCC cells with B7-H3 depletion were established by RNA interference to investigate the effect of B7-H3
on cell proliferation, apoptosis, migration and invasion in vitro.
Results: Statistical analysis of clinical cases revealed that B7-H3 high expression group had inclinations towards
late TNM stage, the presence of vascular invasion, lymph metastasis, and the formation of microsatellite tumors.
Increased intensity of tumor B7-H3 staining was detected more significantly in metastatic HCC tumors. Consistently in
experiments performed in vitro, B7-H3 was able to stimulate the wound healing, metastasis and invasion of hepatoma
cells by targeting epithelial-to-mesenchymal transition (EMT) via JAK2/Stat3/Slug signaling pathway, while no obvious
influence on cell growth and apoptosis.
Conclusion: B7-H3 in the regulation of the metastatic capacity of HCC cells makes itself a promising therapeutic target
for anti-metastasis therapy.
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pathwayIntroduction
Hepatocellular carcinoma (HCC) is the fifth most fre-
quent cancer in the world, and affects more than 1
million people annually worldwide with a mortality
rate almost equal to its incidence [1]. Although great* Correspondence: sundianxing@hotmail.com
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unless otherwise stated.advances in surgical technique and medical care have
been achieved over the last several decades, the 5-year
survival rate worldwide of HCC is still less than 5%,
mainly because of the high rate of recurrence and metas-
tasis [2]. It would be clinically beneficial to discover bio-
logical markers that help predict early tumor metastasis,
identify their molecular mechanisms invasion processes of
HCC patients, and then design a better therapeutic target
for early intervention of cancer invasion and metastasis. In
fact, increasing evidence suggests that HCC metastasis is a
multistep process including tumor cells’ invasion into thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ing into the lumina of blood vessels, extravasating into
the parenchyma of distant organs and then invading
foreign microenvironments in order to form microme-
tastasis [3-5].
B7-H3 (B7 homologue 3), a newly found member of B7/
CD28 superfamily, was identified as an accessory costimu-
latory molecule after initial antigen priming in cooperation
with a putative counterreceptor [6-9]. The role of B7-H3
in adaptive immune responses still remains controversial.
B7-H3 was first identified as a costimulatory molecule that
engages its receptor on T cells to promote T-cell activation
and secretion of IFN-γ [6,10]. Others evidence showed
that B7-H3 played an inhibitory role during autoimmune
diseases [11,12]. In tumor, B7-H3 has been described in a
number of different tumor entities, for example, in pros-
tate, pancreatic and renal cell cancer and neuroblastoma
[7,8,13,14]. Recently, Sun et al. showed that B7-H3 was
abundantly expressed in HCC and involved in evading
anti-tumor immunity, but the specific mechanism was still
elusive [15]. As a tumor-associated antigen, B7-H3 has not
only been attributed to its involvement in tumor immunity
but also plays a non-immunological role in cancer pro-
gression [9]. In 2008, Chen et al. showed for the first time
that downregulation of B7-H3 reduced cell adhesion to fi-
bronectin by up to 50% and migration and invasion by
more than 70% in melanoma and breast cancer cells [16].
In agreement with this, Yuan et al. showed that B7-H3
downregulation led to significant inhibition of cell migra-
tion and invasion of human prostate cancer cells [13].
These results strongly suggest that B7-H3 was involved in
cancer progression and metastasis beyond modulating
tumor immunity.
In this present study, we carried out the immunohisto-
chemistry study to characterize the B7-H3 expression
in human HCC tissues and found a positive correlation
with metastasis of HCC. In addition, we have found
that downregulation of B7-H3 could reduce cell migration
and matrigel-invasion significantly in HCC cells, but
surprisingly had no apparent impact on cell proliferation.
These results could be attributed to the functions of
B7-H3 in the regulation of epithelial to mesenchymal
transition (EMT) process via JAK2/STAT3/Slug pathway.
In conclusion, our data indicate B7-H3 as a readily-
detectable biomarker for tumor recurrence and/or metasta-
sis and suggest an attractive target of B7-H3 for therapeutic
manipulation in the future for multimodal management of
HCC.
Methods
Patients and clinical specimens
According to the following the inclusion and exclusion cri-
teria, 116 HCC tumor tissues and corresponding adjacent
noncancerous liver tissues used in immunohistochemicalanalysis were randomly obtained from patients undergoing
liver curative resection between 2004 and 2008 hospitalized
in department of hepatobiliary surgery, Bethune Inter-
national Peace Hospital and the Fourth Hospital of Hebei
Medical University. (a) distinctive pathologic diagnosis of
HCC, (b) without anticancer treatment before liver resec-
tion, (c) underwent primary and curative resection for
HCC between 2004 and 2008, and (d) complete clinico-
pathologic and follow-up data. 20 normal liver tissues were
also taken from the biopsy tissues of healthy living donors
for transplantation. All specimens were collected in the op-
erating theater immediately (≤15 min) after resection of
the tumors and then were snap frozen in liquid nitrogen or
fixed in 10% buffered formalin solution and embedded in
paraffin for histological analysis. The histologic grade of
tumor differentiation was determined by the Edmondson-
Steiner grading system. Liver function was assessed by the
Child-Pugh score system. Tumors were classified according
to the WHO classification and the International Union
against Cancer tumor-node-metastasis (TNM) classifica-
tion. If patients had multiple lesions in the liver, we selected
the main nodule for our study. All samples were obtained
with informed consent and their use was approved by the
ethics committee of the institution. The median follow-up
period was 33.5 months (range, 9–62 months; standard de-
viation [SD], 11.6 months). At the last follow-up (Dec 31st,
2012), 79 (68.1%) patients finally died, including 32 due to
liver failure or bleeding from the gastrointestinal tract and
the remaining 47 cases due to tumor recurrence.
Cell lines and culture conditions
Human HCC cell lines (HepG2 and SMCC-7721) were
obtained from the Cell Bank of the Chinese Academy of
Sciences (Shanghai, China) and cultured according to
the instructions from American Type Culture Collection
(ATCC). The cells were maintained in high-glucose
DMEM (Gibco) supplemented with 10% fetal calf serum
(Gibco). The cells were incubated at 37°C in a humidified
chamber containing 5% CO2.
Antibodies
Goat anti-B7-H3 was purchased from R&D company for
immunohistochemistry. B7-H3 monoclonal antibody
(Biolegend MIH35) was used in vitro experiment. Rabbit
anti-E-cadherin, anti-N-cadherin, anti-Vimentin, anti-
Slug, and anti-Snail antibodies were purchased from
Abcam company. Rabbit anti-phospho-Stat3 (Tyr705),
Stat3, Phospho-Jak2 (Tyr1008), and Jak2 were purchased
from Cell Signalling Technology. Anti-GAPDH antibody
was purchased from Santa Cruz Biotechnology.
Immunohistochemical staining
Immunohistochemistry was performed using the Dako
EnVision™ method according to the manufacturer’s
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were cut by microtome, dewaxed in xylene and rehydrated
through graded ethanol solutions. Antigens were retrieved
by heating the tissue sections at 100°C for 30 min in
EDTA solution. Sections were cooled down and immersed
in 0.3% H2O2 solution for 20 min to block endogenous
peroxidase activity, and then rinsed in PBS for 5 min,
blocked with 5% BSA at room temperature for 20 min,
and incubated with primary antibodies against B7-H3
(final concentration in use, 5 μg/ml) at 4°C overnight.
Negative controls were performed by replacing the specific
primary antibody with PBS. After three PBS washes, sec-
tions were incubated with secondary antibodies for
30 min at room temperature. Diaminobenzene was used
as the chromogen and hematoxylin as the nuclear coun-
terstain. Sections were dehydrated, cleared and mounted.
Evaluation of B7-H3 staining in cancer cells was evalu-
ated by authorized pathologists who had no knowledge of
the patients’ clinical status and outcome. B7-H3 expres-
sion scores were given separately for the stained area and
for the intensity of staining. Quantification was made as
follows; ≤33% of the cancer cells: 1, >33 to ≤66% of the
cancer cells: 2, >66% of the cancer cells: 3; intensity of
staining: absent/weak: 1, moderate: 2, strong: 3. The inten-
sity of B7-H3 staining was considered weak when either
cytoplasmic expression or rare membranous condensation
was present, moderate when incomplete and discontinu-
ous moderate membranous expression was present, and
strong when complete membranous expression of the
molecule was present. Each section had a final grade that
derived from the multiplication of the area and intensity
scores. Sections with a final score of ≤3 were classified as
tumors with low B7-H3 expression, whereas sections
with a final score of >3 were classified as tumors with
high B7-H3 expression.
B7-H3 siRNA transfection
To further analyze the role of B7-H3 in HCC malig-
nancy, HepG-2 and SMMC7721 cells were tranfected
with B7-H3 shRNA plasmid using Lipofectamine2000
(Invitrogen, CA). Each shRNA vector is cloned in pGFP-
V-RS (Origene Technologies, Inc.) plasmid under U6
promoter for mammalian cell expression. The set se-
quence of the B7-H3 siRNA contains 5 vials of gene-
specific siRNA expression vectors in pGFP-V-RS plas-
mid. We selected the most efficient one to carry out the
following experiment. This sequence of the B7-H3 siRNA
is 5′-TGAAACACTCTGACAGCAAAGAAGATGAT-3′.
The plasmid contains a non-effective siRNA cassette
against green fluorescent protein as a scrambled negative
control (Origene Technologies, Inc.) In brief, about 3 ×
105 cells were seeded per well in a 6 well plate. After 24 h,
the cells were transfected with 1.5 μg of cDNA or siRNA
plasmid for 6 h, and the media were replaced with freshgrowth medium. At 48 h after transfection, cells were har-
vested for analysis. Transfection efficiency was evaluated
by RT-PCR and western blotting assay, respectively.
Cell proliferation by MTT assay
The MTT assay was used to study the effect of B7-H3
siRNA interference on HCC cell proliferation. Cells were
seeded at a density of 5 × 103 cells per well in 200 μl of
DMEM medium into 96-well plates, and cultured over-
night. At different time points, the medium was replaced
with 100 μl fresh medium containing 0.5 mg/ml MTT
(Sigma, USA). Four hours after the addition of MTT, the
supernatants were removed and discarded. 150 μl of
dimethylsulfoxide (DMSO, Sigma) was added to each
well to dissolve the crystals. Cell viability was deter-
mined by scanning with a microplate reader at a wave-
length of 490 nm. Each experiment was performed in
triplicate and repeated at least three times.
Apoptosis assay
The induction of apoptosis by B7-H3 siRNA transfection
was evaluated with a Cell Death Detection ELISAPlus kit
(Roche, Germany) according to the manufacturer’s in-
struction. Cells were cultured in 96-well plates, starved
by serum deprivation for 24 h. Then, cells were trans-
fected with B7-H3 siRNA or scrambled non-target
siRNA for 24, 48 and 72 h as indicated. Measurements
were made using an ELISA reader at 405 nm. Each
group was repeated in six wells and the results were
averaged.
Scratch wound healing assay
B7-H3 or control siRNA transfected HCC cells were
preincubated with serum-free medium for 24 h, and cell
layers were scraped with a pipette tip when cells reached
80% confluence. Cells were then washed twice with PBS
and incubated in serum-free medium at 37C in a 5% CO2
incubator for 24 h. Photographs were taken at different
times from 0 to 48 h. Wound width was measured at
200 ×magnification using a BX50 microscope (Olympus®).
Ten measurements were made at random intervals along
the wound length. Data were averaged and expressed as
the mean wound distances. This experiment was done in
triplicate.
Invasion assay
Invasion assays were done using transwell matrigel inva-
sion chambers with a pore size of 8 μm coated with
1 μg/cm2 to 2 μg/cm2 martigel (BD, USA). Cells were
detached and resuspended in serum-free DMEM. A total
of 2 × 104 cells in 100 μl of serum-free media were
seeded onto the upper portion of a 24-well matrigel
chamber. The lower compartment contained DMEM
with 10% FBS. After incubation at 37°C for 24 h in a 5%
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removed from the upper chamber with cotton tipped
swabs. The cells were rinsed with PBS and cells on the
filters were fixed with methanol for 30 min and stained
with crystal violet solution. The number of invading
cells on the filters was counted in 5 random fields per
filter at 200× magnification in triplicate wells of each
group.Western blotting
HCC cells were washed with PBS twice and lysed with
1 mL RIPA lysis buffer containing protease and phos-
phatase inhibitor for 30 min on ice. After removing the
insoluble material by 12,000 × g centrifugation for
30 min at 4°C, the supernatants were collected. Cell lysate
protein content was determined using a Bicinchoninic
acid (BCA) protein assay kit. Equivalent amounts of whole
cell extracts were subjected to SDS-PAGE and transferred
to PVDF membranes. The membranes were blocked
with 5% non-fat milk for 2 h and then incubated with
respective primary antibody overnight at 4°C followed
by the incubation with the appropriate HRP-conjugated
secondary antibody for 2 h at room temperature. Blots
were visualized with an ECL detection kit (Pierce, USA)
and GAPDH was used as a loading control.
Gelatin zymography
For MMP-2 and MMP-9 activity detection, cell lysate
from treated cells were prepared and subjected to electro-
phoresis with 8-12% SDS polyacrylamide gels containing
0.1% gelatin. After electrophoresis, the gels were washed
with 2.5% Triton X-100 for 30 min to remove SDS and
incubated in a reaction buffer at 37°C for 16 h. Finally,
the gels were stained with 0.5% Coomassie brilliant
blue R-250 solution containing 10% acetic acid and
20% methanol for 30 min and then destained with 7.5%
acetic acid solution containing 10% methanol. Areas ofFigure 1 Representative immunohistochemical analysis of B7-H3 express
(A) Strong positive, (B) Moderate positive, (C) Weak positive. B7-H3 immunostai
tumor (F). Higher B7-H3 expression was often observed in tumor cells at the tugelatinase activity appear as clear bands against the
blue-stained gelatin background.
Statistical analysis
The Mann–Whitney U test, χ2 test or Spearman rho test
were performed for comparative statistical evaluations
among groups and for correlation analysis with histo-
logical and clinical parameters (age, gender, tumor stage,
tumor grade, and postoperative survival). The Kaplan-
Meier method was used to analyze survival data and the
log-rank test was taken to control differences in patients’
survival. Other data are shown as the mean and range or
mean ± SD of 3 independent experiments. Statistical
comparisons were performed using Student’s t test. All p
values were determined by 2-sided tests with significance
considered at p < 0.05 using SPSS 20.0 for Windows.
Results
Increased B7-H3 expression is significantly correlated with
HCC metastasis
Among the examined 116 HCC tissues, 109 showed
positive B7-H3 protein expression in tumor cells. In our
case series, the expression of B7-H3 was variably positive
in HCC tumor cells and weak and focal positive or nega-
tive in normal hepatic tissue (Figure 1A-F). A total of
79.3% of tumor samples were identified as high B7-H3
staining, while 20.1% showed a low degree of B7-H3
staining. High expression of B7-H3 correlated significantly
with late TNM stage (p = 0.038), the presence of vascular
invasion (p = 0.001), lymph metastasis (p = 0.041), and the
formation of microsatellite tumors (p = 0.016), which is
considered evidence of intrahepatic tumor metastasis
(Table 1). Interestingly, increased expression of B7-H3 was
often observed in tumor cells at the edge of the tumor and
in cells invading to surrounding tissue (Figure 1G).
To investigate the correlation between B7-H3 overex-
pression and HCC metastasis, the expression level of B7-
H3 was analyzed in 32 pairs of HCCs samples includingion in tissue sections of HCC. B7-H3 immunostaining in HCC tissues
ning in HCC adjacent liver tissues (D), normal liver tissues (E) and metastatic
mor edge (G), invading (arrows) to surrounding tissue, ×200 magnification.
Table 1 Relationship between B7-H3 expression and
clinico-pathological parameters in HCC
Index Case B7-H3 expression
Low High p
Age (y)
≤50 43 9 34 0.570
>50 73 15 58
Gender
Male 84 16 68 0.320
Female 32 8 24
Vascular Invasion
+ 50 3 47 0.001
- 66 21 45
TNM stage
I-II 20 57 77 0.038
III-IV 4 35 39
Lymph metastasis
+ 32 3 29 0.041
- 84 21 63
Tumor size (cm)
≤5 77 21 56 0.010
>5 39 3 36
Tumor encapsulation
+ 18 1 17 0.071
- 98 23 75
Microsatellite tumors
Yes 31 2 29 0.016
No 85 22 63
Child-Pugh classification
A 60 13 47 0.485
B 56 11 45
Liver cirrhosis
weak 24 8 16 0.203
moderate 58 10 48
strong 34 6 28
HBsAg
+ 76 13 63 0.142
- 40 11 29
AFP
≤200 48 8 40 0.242
>200 67 16 51
Transfusion
+ 47 8 39 0.286
- 69 16 53
Values in bold signify p < 0.05.
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primary metastatic HCCs patients at first diagnosis. In-
creased intensity of tumor B7-H3 staining was detected
more significantly in metastatic HCC tumors (p = 0.019,
Wilcoxon signed rank test; Table 2). These data further
support the hypothesis that B7-H3 plays an important role
in HCC metastasis.
Increased B7-H3 expression is predictive of poor survival
in HCC patients
Of the 116 patients with HCC who underwent hepatic re-
section, 79 (68.1%) finally died. We analyzed the prognos-
tic significance by comparing carcinomas with high B7-H3
levels to those with low B7-H3 expression. The low-B7-
H3 group showed significantly better overall survival
than the high-B7-H3 group (log-rank test, p = 0.011). A
Kaplan–Meier curve regarding the association between
B7-H3 expression in tumor cell and overall survival is
shown in Figure 2A. The median survival in patients
with low tumor B7-H3 expression was 37.1 ± 4.62 months
and 29.2 ± 1.27 months in patients with high B7-H3 ex-
pression. After univariate analysis, HCC patients with
high-B7-H3 tumor cells were more likely to die compared
with counterparts with low-B7-H3 tumors (risk ratio,
2.275; 95% CI, 1.166-4.438; p = 0.016). After adjustment
for the TNM stage, vascular invasion and lymph metasta-
sis, patients with high-B7-H3 tumor cells remained signifi-
cantly more likely to die from HCC compared with
patients with low-B7-H3 tumors (risk ratio, 2.586; 95% CI,
1.271-5.260; p = 0.009). In addition, B7-H3 staining inten-
sity was also associated with HCC patients’ survival. Cases
with a strong or moderate B7-H3 staining intensity in
HCC showed a significantly shortened mean survival time
compared to the cases with weaker staining (log-rank test,
p = 0.010) (Figure 2B). Therefore, these data suggested that
B7-H3 expression might be functionally important in
tumor progression of HCC, and high tumor B7-H3 ex-
pression predicts poor prognosis for HCC patients.
Silenced B7-H3 expression has no obvious effect on HCC
cell proliferation and apoptosis
Cultured HCC cell lines (HepG2 and SMMC7721) all
constitutively expressed B7-H3 at both mRNA and protein
level. RT-PCR results showed that there was markedly de-
creased gene expression after silencing B7-H3 for 24 h
compared with the control groups. Accordingly, a similar
decrease was also found in protein synthesis and secretion
after 48 h in B7-H3 knockdown cells (Additional file 1:
Figure S1).
To characterize the role of B7-H3 in HCC cell growth,
we measured cell proliferation rate in vitro by MTT
assay. Results showed that there was no statistical sig-
nificance in cellular proliferation between the parental,
scramble siRNA-transfected and B7-H3 silenced cells
Table 2 B7-H3 intensity in 32 pairs of primary HCCs and matched metastatic HCCs
B7-H3 intensity of matched metastatic HCCs Total
weak moderate strong
B7-H3 intensity of primary HCCs weak 1 3 2 6 (18.8%)
moderate 0 7 5 12 (37.4%)
strong 0 2 12 14 (43.8%)
Total 1 (0.04%) 12 (37.5%) 19 (59.4%) 32
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that downregulation of B7-H3 did not increase cell
apoptosis, compared with the other two control cells
(Figure 3C-D).
Silenced B7-H3 expression suppresses scratch wound
healing ability of HCC cells
We next examined the cytological effect of B7-H3 on
movement ability of HCC cells by scratch healing assay.
Results showed that depletion of B7-H3 in HepG2 and
SMMC7721 cell lines could not contribute to healing
the wound 48 h after scratching, in contrast to the par-
ental cells and empty vector-transfected cells which were
significantly more efficient in healing, as indicated by
the mean wound distances (Figure 4). To further con-
firm the function of B7-H3 in HCC cells, HepG2 cells
were cultured in the presence or absence of anti-B7-H3
mAbs (10 μg/ml). Results showed that the cells in the
control group migrated faster than those in the B7-H3
blockade group (Additional file 2: Figure S2A).
Silenced B7-H3 expression suppresses invasion of HCC
cells
In order to further assess the influence of B7-H3 on HCC
cells’ invasion, we employed cell transwell invasion assays
to determine the key factor of malignant progression and
metastasis upon B7-H3 downregulation. As shown in re-
sult, downregulation of B7-H3 led to significantly sup-
pressed invasive ability of both HepG2 and SMMC-7721Figure 2 Kaplan-Meier overall survival curve of HCC patients in correlationcells (Figure 5). Number of invasive HepG2 B7-H3 knock-
down cells is significantly lower compared to the control
groups after 24 h (82.17 ± 7.00 vs 243.26 ± 14.07 and
208.37 ± 23.98, p < 0.05). Similarly, number of invasive
SMMC-7721 B7-H3 knockdown cells is significantly lower
compared to the control groups after 24 h (53.08 ± 6.16 vs
261.12 ± 11.07 and 283.52 ± 17.13, p < 0.05). The similar
results were also observed in HCC cells after in the pres-
ence or absence of anti-B7-H3 mAbs (Additional file 2:
Figure S2B). These results displayed an enhanced effect of
B7-H3 on hepatocellular carcinoma cells invasion.
Silenced B7-H3 expression suppresses migration and
invasion of HCC cells by targeting EMT via JAK2/Stat3/slug
signaling pathway
Results showed loss of B7-H3 decreased the expression
and activity of matrix metalloproteinase-2 (MMP-2) and
MMP-9 significantly in both B7-H3-siRNA transfected
HCC cell lines (Figure 6). In addition, B7-H3 is also in-
volved in EMT process of HCC cells. After knockdown of
B7-H3, the expressions of E-cadherin was up-regulated,
while N-cadherin and Vimentin were down-regulated in
each B7-H3 silenced groups compared with the negative
control group (Figure 6). These results suggested that B7-
H3 may play an important role in EMT in human hepato-
cellular carcinoma.
JAK/Stat pathway is critical for cytokine and growth
factor-mediated responses regulating EMT biology in
fibrogenesis and cancer [17]. In the light of the evidencewith B7-H3 expression (A) and its intensity level (B).
Figure 3 B7-H3 siRNA interference effects on HepG2 and SMMC7721 cell proliferation (A-B) and apoptosis (C-D). Data represent mean ± SEM of
three independent experiments.
Figure 4 B7-H3 siRNA interference effects on HepG2 (A-B) and SMMC7721 (C-D) cell migration by wound healing analysis. The confluent cells
were wounded by sterile pipettes and the status of wound closure were observed and photographed after 48 h. All the experiments were
repeated for three times (magnification, 200×).
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Figure 5 B7-H3 siRNA interference effects on HepG2 (A-B) and SMMC7721 (C-D) cell invasion by transwell chamber assay. Representative
photographs of invasive HepG2 and SMMC7721 cells on the membrane, all the experiments were repeated for three times (magnification, 200×).
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the role of Stat3 in cell motility and EMT [19], this study
sought to directly examine the role of this pathway in
B7-H3-induced EMT in HCC cells. After treatment of
B7-H3 siRNA, the protein level of p-sata3 and p-JAK2
was dramatically reduced in HepG2 and SMMC7721
cells transfected with B7-H3 siRNA plasmids, while no
influence on the total expression of Stat3 and JAK2,
compared with control shRNA plasmids (Figure 6). In
addition, EMT-related transcription factors Slug was
downregulated after B7-H3 silenced (Figure 6), whereas
Snail seemed to be not significantly affected. The similar
results were also observed in HCC cells after in the pres-
ence or absence of anti-B7-H3 mAbs (Additional file 2:
Figure S2C-D). This result could be the explanation that
B7-H3 may regulate EMT process of HCC via partially
activating JAK2/ Stat3/Slug signaling pathway.
Discussion
Although curative surgery and chemotherapy offer an
opportunity for HCC patients, the cumulative 5-year re-
currence rate still ranges from 40% to 80% because ofhigh potential for vascular invasion and metastasis
[20,21]. Consequently, the identification of certain cell
surface molecule that is uniformly and stably expressed
by primary and metastatic HCC encompasses a vital
finding and an opportunity to improve HCC treatment.
This is especially true when the function of the molecule
is relatively well defined and can be readily linked to
mechanisms for cancer progression. In the present
study, B7-H3 was more frequently elevated in HCC tis-
sue with late TNM staging, vascular and lymph node in-
volvement and tumor invasion. Higher expression level
of B7-H3 was often detected in tumor cells invading into
the surrounding tissue and blood vessel. Moreover, the
invasive and metastatic effect of B7-H3 in clinical speci-
mens was also addressed by IHC containing in primary
metastatic HCCs’ samples. Increased B7-H3 intensity
level was detected in 59.4% of the metastatic HCC tu-
mors compared other non-metastatic primary HCCs.
These results suggest that HCC is likely to become ag-
gressive and metastatic when B7-H3 expression is high,
suggesting that B7-H3 plays an important role in tumor
invasion of HCC. Furthermore, we also found that
Figure 6 Western blot analysis for protein levels of MMP-2, MMP-9, E-cadherin, Vimentin, N- cadherin, Slug, p-stat3, stat-3, p-JAK2 and JAK2 in
hepatocellular carcinoma cell lines HepG2 and SMMC7721. Protein levels were expressed as the ratio of target protein over GAPDH. All the
experiments were repeated for three times (A). Zymography experiments for detection of the activity of MMP-2 and MMP-9 in hepatocellular
carcinoma cell lines HepG2 and SMMC7721 (B).
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intensity level experienced significantly shorter periods
of postoperative survival. These findings directly demon-
strate the clinical significance of B7-H3 to help tumor cell
escaping form immunosurvillance and further invasion
and metastasis in HCC.
B7-H3 is a new member of B7 family that has been im-
plicated as a potential regulator of antitumor response
[22]. The role of B7-H3 in tumor has been widely studied
and its function has been associated with the regulation of
immune responses [13,16,23]. However, recent work by
Nygren et al. group indicates that B7-H3 also has non-
immunological effects on invasion and chemoresistance in
human cancers [24]. Based on the previous results we
collected, it has reason to believe that B7-H3 might be
involved in HCC cells’ biological process, which in turnstimulated the malignant potency of HCC cells and estab-
lish a vicious cycle of mutually reinforcing mechanisms to
sustain the activity and promotes the malignant behavior
of HCC. Therefore, we silenced B7-H3 in HepG2 and
SMMC7721 cells to explore the effects of B7-H3 in HCC
cells’ biology and its underlying mechanism. Results
showed that a transient knockdown of B7-H3 significantly
suppressed the migratory and invasive ability of HCC cells
in vitro. This suggests that B7-H3 has a putatively import-
ant role in tumor migration and invasiveness, indicating
higher aggressiveness and poor clinical outcome. Many
data have revealed that cell proliferation affected the out-
comes of both transwell assay and wound healing assay
[25], it is essential to examine whether B7-H3 knockdown
affected the proliferation of HepG2 and SMMC7721 cells.
Results showed that the proliferation of B7-H3 siRNA
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controls. Besides, cell apoptosis was also not altered
significantly between B7-H3 siRNA group and controls.
Taken together, these results suggested that knockdown
of B7-H3 decreased the invasion and metastasis of
HCC cells and this inhibitory effect was not dependent
on the proliferation of tumor cells.
MMPs are a family of related zinc-dependent protein-
ases that are believed to play important role in the invasive
process and metastasis of cancer cells [26]. Among them,
MMP-2 and MMP-9 are the most concerned and their
functions have been well-characterized in HCC [27,28].
Our previous study revealed that B7-H3 regulated inva-
sion of osteosarcoma cells at least partly through MMP-2
[29]. Tekle et al. also reported that B7-H3 contributed to
the metastatic capacity of melanoma cells by modulation
of MMP-2 and signal transducer and activator of Stat3
[30]. In this present study, we show that B7-H3 depletion
could lead to the decreased expression and activity of
MMP-2 and MMP-9 in HCC cells, indicating that a de-
creased metalloproteinase activity in the B7-H3 knock-
down cells, which at least partly might explain the reduced
invasive capacity of these cells.
Metastasis generally involves shedding of tumor cells
from the primary sites and their infiltration into peripheral
tissues, which is caused by various factors, where intercel-
lular adhesion is reduced and thus tumor cells adhere to
the basal membrane and then move out of the primary
site as the extracellular matrix is degraded [31,32]. The
EMT is a key event for cancerous cells to acquire the cap-
ability of migration and invasion of HCC cells [33]. These
processes are tightly regulated by temporally and spatially
regulated expression and activation of many signal mole-
cules [17,34]. To better elucidate the invasive and meta-
static mechanisms of B7-H3, the effect of B7-H3 depletion
on the EMT was investigated. As expected, the epithelial
markers E-cadherin were up-regulated, whereas the mes-
enchymal markers N-cadherin and vimentin were down-
regulated in B7-H3 siRNA-tranfected cells. Moreover, we
observed that the EMT-related transcription factors
Slug was downregulated after B7-H3 silenced and phos-
phorylation levels of Stat3 and JAK2 were decreased.
All of these results clearly demonstrated that the EMT
induced by B7-H3 partially via JAK2/Stat3/Slug signaling
pathway is an important mechanism underlying HCC
development and metastasis. Furthermore, this could
be the reason why B7-H3 overexpression is correlated
with higher incidence of intrahepatic metastasis and re-
currence in immunohistochemistry.
To conclude, the overexpression of B7-H3 in HCC cre-
ates a milieu of pro-metastatic factors that may play a role
in very early and/or reactivated intrahepatic metastasis. A
mechanism by which B7-H3 knockdown inhibits the
EMT process and JAK2/STAT3/Slug signaling pathwayplays important role in this process. This finding supports
the possibility of B7-H3 and/or its associated molecules as
targets for anti-metastatic therapy in HCC.
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